RECURRENT NASOPHARYNGEAL CARCINOMA—TWO LONG TERM DISEASE‐FREE REMISSIONS WITH NON‐CISPLATINUM BASED COMBINATION CHEMOTHERAPY

I. E. Haines; M. A. Schwarz; R. A. Hurley; H. M.P. Rundle

doi:10.1111/j.1445-2197.1985.tb00876.x

RECURRENT NASOPHARYNGEAL CARCINOMA—TWO LONG TERM DISEASE‐FREE REMISSIONS WITH NON‐CISPLATINUM BASED COMBINATION CHEMOTHERAPY

I. E. Haines, M. A. Schwarz, R. A. Hurley, H. M.P. Rundle

Medicine Alfred Hospital

Research output: Contribution to journal › Article › Research › peer-review

5 Citations (Scopus)

Abstract

Two cases of locally recurrent nasopharyngeal carcinoma following maximal radiotherapy are presented. Both patients had complete resolution of disease with outpatient combination chemotherapy using Vincristine, Adriamycin and Cyclophosphamide (VAC), and are disease free, and working full time, 3 and 4 years later, respectively. The significant relapse rate of nasopharyngeal carcinoma after initial radiotherapy is outlined, and the reported limitations of radiotherapy and chemotherapy in this situation are discussed. The survival curve for this disease appears to plateau at 2–3 years. This appears to be the first reported outpatient combination chemotherapy programme to produce long term disease‐free remission in recurrent disease.

Original language	English
Pages (from-to)	153-156
Number of pages	4
Journal	Australian and New Zealand Journal of Surgery
Volume	55
Issue number	2
DOIs	https://doi.org/10.1111/j.1445-2197.1985.tb00876.x
Publication status	Published - 1 Jan 1985

Keywords

chemotherapy
recurrent nasopharyngeal carcinoma

Access to Document

10.1111/j.1445-2197.1985.tb00876.x

Cite this

@article{f2fb820a54c44161ace25b8f0f7b8e65,

title = "RECURRENT NASOPHARYNGEAL CARCINOMA—TWO LONG TERM DISEASE‐FREE REMISSIONS WITH NON‐CISPLATINUM BASED COMBINATION CHEMOTHERAPY",

abstract = "Two cases of locally recurrent nasopharyngeal carcinoma following maximal radiotherapy are presented. Both patients had complete resolution of disease with outpatient combination chemotherapy using Vincristine, Adriamycin and Cyclophosphamide (VAC), and are disease free, and working full time, 3 and 4 years later, respectively. The significant relapse rate of nasopharyngeal carcinoma after initial radiotherapy is outlined, and the reported limitations of radiotherapy and chemotherapy in this situation are discussed. The survival curve for this disease appears to plateau at 2–3 years. This appears to be the first reported outpatient combination chemotherapy programme to produce long term disease‐free remission in recurrent disease.",

keywords = "chemotherapy, recurrent nasopharyngeal carcinoma",

author = "Haines, {I. E.} and Schwarz, {M. A.} and Hurley, {R. A.} and Rundle, {H. M.P.}",

year = "1985",

month = jan,

day = "1",

doi = "10.1111/j.1445-2197.1985.tb00876.x",

language = "English",

volume = "55",

pages = "153--156",

journal = "Australian and New Zealand Journal of Surgery",

issn = "0004-8682",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - RECURRENT NASOPHARYNGEAL CARCINOMA—TWO LONG TERM DISEASE‐FREE REMISSIONS WITH NON‐CISPLATINUM BASED COMBINATION CHEMOTHERAPY

AU - Haines, I. E.

AU - Schwarz, M. A.

AU - Hurley, R. A.

AU - Rundle, H. M.P.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - Two cases of locally recurrent nasopharyngeal carcinoma following maximal radiotherapy are presented. Both patients had complete resolution of disease with outpatient combination chemotherapy using Vincristine, Adriamycin and Cyclophosphamide (VAC), and are disease free, and working full time, 3 and 4 years later, respectively. The significant relapse rate of nasopharyngeal carcinoma after initial radiotherapy is outlined, and the reported limitations of radiotherapy and chemotherapy in this situation are discussed. The survival curve for this disease appears to plateau at 2–3 years. This appears to be the first reported outpatient combination chemotherapy programme to produce long term disease‐free remission in recurrent disease.

AB - Two cases of locally recurrent nasopharyngeal carcinoma following maximal radiotherapy are presented. Both patients had complete resolution of disease with outpatient combination chemotherapy using Vincristine, Adriamycin and Cyclophosphamide (VAC), and are disease free, and working full time, 3 and 4 years later, respectively. The significant relapse rate of nasopharyngeal carcinoma after initial radiotherapy is outlined, and the reported limitations of radiotherapy and chemotherapy in this situation are discussed. The survival curve for this disease appears to plateau at 2–3 years. This appears to be the first reported outpatient combination chemotherapy programme to produce long term disease‐free remission in recurrent disease.

KW - chemotherapy

KW - recurrent nasopharyngeal carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0022253572&partnerID=8YFLogxK

U2 - 10.1111/j.1445-2197.1985.tb00876.x

DO - 10.1111/j.1445-2197.1985.tb00876.x

M3 - Article

C2 - 3862387

AN - SCOPUS:0022253572

SN - 0004-8682

VL - 55

SP - 153

EP - 156

JO - Australian and New Zealand Journal of Surgery

JF - Australian and New Zealand Journal of Surgery

IS - 2

ER -

RECURRENT NASOPHARYNGEAL CARCINOMA—TWO LONG TERM DISEASE‐FREE REMISSIONS WITH NON‐CISPLATINUM BASED COMBINATION CHEMOTHERAPY

Abstract

Keywords

Access to Document

Other files and links

Cite this